Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Identification of potential novel biomarkers to differentiate malignant thyroid nodules with cytological indeterminate

Fig. 3

Validation of the gene expression levels of novel biomarkers between histopathological benign and malignant. a Expression comparison of 24 signature genes among benign and malignant cases groups; b Validation the expression level of potential biomarkers of FN1, TENM1, SCEL, SCL34A2, PROS1. c Validation based on TCGA data via GEPIA, including FN1, TENM1, SCEL, SCL34A2, PROS (***, represent p value < 0.0001; *, represents p value < 0.01)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us